Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Culprits of Biotech's Malaise: Let's Also Look in the Mirror
Forbes
Thursday, October 13, 2011 - 11:33am
tags:
biotech
The Disconnect Continues: Amgen Rethinks R&D
Pharmalot
Thursday, October 13, 2011 - 11:31am
tags:
Amgen, R&D
Asthma Drug Spending Soars in U.S.
National Journal, Washington DC
Thursday, October 13, 2011 - 11:00am
tags:
asthma
Johnson & Johnson Third Quarter Earnings Sneak Peek
Yahoo/Wall St. Cheat Sheet
Thursday, October 13, 2011 - 10:57am
tags:
earnings, JNJ, Amgen, Abbott Laboratories, Boston Scientific
Vertex Shares Rise on Optimism for Higher Incivek Sales
Bloomberg
Thursday, October 13, 2011 - 10:56am
tags:
Incivek, Vertex, hepatitis C
Horizon Pharma Receives U.S. Patent Allowance for DUEXIS(R) in the United States
Yahoo
Thursday, October 13, 2011 - 10:55am
tags:
Duexis, Horizon Pharma, ulcers
J&J Didn’t Warn Levaquin Riskier Than Rivals, Lawyer Argues
Bloomberg
Thursday, October 13, 2011 - 10:53am
tags:
JNJ, antibiotics, Levaquin, Ortho-McNeil-Janssen
Positive Data on Forest Candidate
Yahoo/Zacks.com
Thursday, October 13, 2011 - 10:52am
tags:
Forest Labs, antipsychotics, Bristol-Myers Squibb, Eli Lilly, cariprazine
FDA green lights improved inhaler for Boehringer COPD drug
Fierce Drug Delivery
Wednesday, October 12, 2011 - 10:52am
tags:
FDA, COPD, Combivent Respimat, Boehringer Ingelheim
Teva's Copaxone reduced brain volume loss in patients, according to study
Drugstore News
Wednesday, October 12, 2011 - 10:51am
tags:
Copaxone, Teva Pharmaceuticals, MS, multiple sclerosis
Dendreon to amp up DTC support for Provenge
Fierce Pharma
Wednesday, October 12, 2011 - 10:43am
tags:
DTC, Provenge, prostate cancer, Dendreon
8 Biotech Stocks Seeing Bearish Options Sentiment
Seeking Alpha
Wednesday, October 12, 2011 - 10:42am
tags:
Acorda, Cytori, Indenix, Vical, Medivation, Optimer Pharmaceuticals, Vertex Pharmaceuticals, XenoPort
AMAG Board Says Shareholders Should Vote for Allos Purchase
Bloomberg
Wednesday, October 12, 2011 - 10:41am
tags:
M&A, Allos, Amag Pharmaceuticals
Pfizer Settles Norplant Lawsuits For $29.5 Million
Pharmalot
Wednesday, October 12, 2011 - 9:28am
tags:
Norplant, Pfizer, settlements
Pfizer Tries to Block Merck Lipitor-Zetia Pill
WSJ Online
Wednesday, October 12, 2011 - 9:27am
tags:
Merck, Pfizer, Lipitor, Zetia, generics
Good Sign For Cytori Therapeutics: Athletes Seek Out Stem Cell Therapy
Seeking Alpha
Wednesday, October 12, 2011 - 9:25am
tags:
Cytori, stem cells
Onyx Pharmaceuticals extends oncology working relationship with Bayer
Yahoo/AP
Wednesday, October 12, 2011 - 9:25am
tags:
Bayer, ONYX Pharmaceuticals, regorafenib
The Medicines Company Needs More Options Beyond Angiomax
Bloomberg
Wednesday, October 12, 2011 - 9:23am
tags:
Angiomax, Medicines Company, Teva Pharmaceuticals
Merck’s Australian Unit Wins Bid to Overturn Trial Decision on Vioxx Drug
Bloomberg
Wednesday, October 12, 2011 - 9:21am
tags:
Merck, Australia, Vioxx
Dividend Leaders Abbott, Baxter See Q3 EPS Growth
Investors.com
Wednesday, October 12, 2011 - 9:20am
tags:
earnings, dividends, Abbott Laboratories, Baxter

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.